drugset / Trial / NCT00470574

Vaccine Therapy and QS21 in Treating Patients With Metastatic Breast Cancer

NCT00470574

NaSingle-groupOpen-labelTreatment

Summary

RATIONALE: Vaccines may help the body build an effective immune response to kill tumor cells. Giving vaccine therapy together with QS21 may cause a stronger immune response and kill more tumor cells. PURPOSE: This clinical trial is studying the side effects and how well giving vaccine therapy together with QS21 works in treating patients with metastatic breast cancer.

Timeline

Start
2007-03-20
Primary completion
2020-01-24
Completion
2020-01-24

Drugs

EvaluationDrugModalityDoseRoute
Subject QS-21 Other / unclassified Subcutaneous
Subject sialyl Lewisª-keyhole limpet hemocyanin conjugate vaccine Vaccine Subcutaneous

Indications